QA: Agios Pharmaceuticals INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001439222_2014_Agios_Pharmaceuticals_INC.pdf

Logs

warning No LiabilitiesAndStockholdersEquity node found input.sec.calculation_linkbase.edgar_model_mapping {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'AvailableForSaleSecuritiesNoncurrent', 'PropertyPlantAndEquipmentNet', 'RestrictedCashAndCashEquivalentsNoncurrent', 'DeferredTaxAssetsNetNoncurrent', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'AvailableForSaleSecuritiesDebtSecuritiesCurrent', 'UnbilledContractsReceivable', 'PrepaidExpenseAndOtherAssetsCurrent', 'DeferredTaxAssetsNetCurrent', 'AccountsPayableCurrent', 'LiabilitiesCurrent', 'AccruedLiabilitiesCurrent', 'AccruedIncomeTaxesCurrent', 'DeferredRevenueCurrent', 'DeferredRentCreditCurrent', 'DeferredCompensationShareBasedArrangementsLiabilityCurrent', 'PreferredStockValue', 'StockholdersEquity', 'CommonStockValue', 'AdditionalPaidInCapitalCommonStock', 'AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', 'RetainedEarningsAccumulatedDeficit'))"}

Graph

Absolute values for 0001439222, Agios Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 169,747,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,758,000
3 remainder_Assets 27,700,000
4 LiabilitiesCurrent 36,930,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,929,000
9 ResearchAndDevelopmentExpense 54,502,000
10 remainder_Expenses 579,000
11 remainder_Revenues 25,548,000
12 remainder_NetIncome 55,000
13 remainder_ComprehensiveNetIncome 16,000
  yvar yval
0 Assets 201,205,000
1 Liabilities 36,930,000
2 Expenses 65,010,000
3 Revenues 25,548,000
4 StockholdersEquity 164,275,000
5 NetIncome -39,407,000
6 ComprehensiveNetIncome -39,399,000
7 BaseVar 164,382,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.68
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution